Davidson Investment Advisors Has $19.48 Million Holdings in Corteva, Inc. $CTVA

Davidson Investment Advisors trimmed its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 5.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 230,036 shares of the company’s stock after selling 13,776 shares during the period. Davidson Investment Advisors’ holdings in Corteva were worth $19,482,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of CTVA. EFG International AG acquired a new stake in shares of Corteva in the second quarter valued at $25,000. Compass Financial Management LLC bought a new stake in Corteva during the 2nd quarter worth about $25,000. Elevation Wealth Partners LLC grew its holdings in Corteva by 334.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after acquiring an additional 261 shares during the last quarter. Clearstead Trust LLC acquired a new stake in Corteva in the 2nd quarter valued at about $31,000. Finally, JPL Wealth Management LLC bought a new position in shares of Corteva in the third quarter worth about $25,000. Institutional investors own 81.54% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CTVA. CICC Research upped their target price on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $101.00 price objective on shares of Corteva in a research report on Monday, August 3rd. Citigroup upped their price objective on Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a report on Monday, August 3rd. Oppenheimer increased their price objective on Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research report on Thursday, July 23rd. Finally, BNP Paribas Exane lifted their target price on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $91.50.

Corteva Trading Up 1.9%

CTVA opened at $84.00 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The company has a market cap of $56.04 billion, a price-to-earnings ratio of 55.63, a price-to-earnings-growth ratio of 2.58 and a beta of 0.57. The firm has a 50 day simple moving average of $82.69 and a 200 day simple moving average of $80.54. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $90.97.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same period last year, the firm earned $2.20 earnings per share. The business’s revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, sell-side analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.